New report by UNITAID on genetically modified mosquitoes 

UNITAID has released its ‘Genetically Modified Mosquitoes: Technology and Access Landscape Report‘, highlighting the potential of genetically modified mosquitoes as a new tool to fight vector-borne diseases, like malaria.  

The report highlights that mosquito-borne diseases like malaria and dengue are spreading faster due to factors such as  temperatures rising and insecticide resistance, and explores the potential of genetically modified mosquitoes and what’s needed to translate research and innovation into real-world impact. Target Malaria’s work is featured alongside Transmission Zero, Oxitec, Synvect and University of California Malaria Initiative (UCMI). 

The African continent bears the heaviest burden of malaria and other mosquito-borne illnesses in the world, and the path forward is clear: with strong African ownership, sustained investment, and the courage to innovate, the world can unlock new strategies to control mosquito populations and ultimately end malaria. 

Unitaid is a global health initiative that funds innovative solutions to prevent, diagnose, and treat major diseases in low- and middle-income countries. publishes a wide range of reports, strategy documents, and issue briefs that highlight its work in global health innovation, market access, and disease response.